Current Report Filing (8-k)
May 05 2021 - 3:06PM
Edgar (US Regulatory)
0001083446
false
0001083446
2021-05-03
2021-05-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 5, 2021 (May 3, 2021)
APOLLO MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its
charter)
Delaware
|
001-37392
|
95-4472349
|
(State or Other Jurisdiction
|
(Commission File
|
(I.R.S. Employer
|
of Incorporation)
|
Number)
|
Identification Number)
|
1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA 91801
(Address of principal executive offices) (zip
code)
(626) 282-0288
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
AMEH
|
Nasdaq Capital Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02
|
Results of Operations and Financial Condition.
|
On May 5, 2021, Apollo
Medical Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended
March 31, 2021. A copy of the press release and supplemental data are attached hereto as Exhibit 99.1 and 99.2, respectively, and
incorporated herein by this reference.
In accordance with General
Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 2.02, including Exhibit 99.1 and Exhibit 99.2 furnished herewith,
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in such filing.
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
(b) Termination of Dr. Adrian Vazquez as Chief
Medical Officer
On May 3, 2021, Network Medical
Management, Inc., (“NMM”), a wholly-owned subsidiary of the Company, notified the Company’s Chief Medical Officer, Adrian
Vazquez, M.D. that, in accordance with that certain Employment Agreement, dated June 8, 2020, between NMM and Dr. Vazquez, his employment
would be terminated effective as of the date that is thirty (30) days after the notification date. Dr. Vazquez will continue in his current
position with the Company until such termination date.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
APOLLO MEDICAL HOLDINGS, INC.
|
|
|
May 5, 2021
|
By:
|
/s/ Thomas S. Lam
|
|
Name:
|
Thomas S. Lam, M.D., M.P.H.
|
|
Title:
|
Co-Chief Executive Officer and President
|
Apollo Medical (NASDAQ:AMEH)
Historical Stock Chart
From Apr 2024 to May 2024
Apollo Medical (NASDAQ:AMEH)
Historical Stock Chart
From May 2023 to May 2024